Biomiga Diagnostics

What Biomiga Diagnostics does

Biomiga Diagnostics (legal entity Biomiga, Inc.) is a privately held molecular biology tools manufacturer headquartered in San Diego, California, operating from an FDA-registered, ISO 9001:2015 certified facility. Founded in 2004, the company builds and sells a comprehensive reagent and instrumentation portfolio spanning nucleic acid extraction (spin-column EZgene™ and magnetic bead MgPure platforms), PCR/qPCR detection chemistries and master mixes, multiplex infectious disease diagnostic panels (respiratory, STI, UTI, pneumonia, wound, GI, women health, fungal, monkeypox), viral vector purification kits for gene and cell therapy workflows (ViraTrap™ for AAV, lentivirus, adenovirus, retrovirus), and benchtop automation systems (Mini-16, Mini-32 extractors and the CB-12/AP-6 plasmid maxiprep platform). The underlying technology stack is anchored by proprietary chemistries including the Ezgene™ binding matrix and MgPure superparamagnetic 50nm Fe3O4 beads, with the company claiming 20-50% cost advantage and 10-20% yield improvement over incumbent SPRI bead products like AMPure XP.

The company serves a horizontally diversified customer base across clinical diagnostics laboratories, gene and cell therapy developers, NGS and genomics core facilities, oncology and liquid biopsy researchers, pharma and biopharma manufacturers, and agricultural and environmental testing labs. The go-to-market model combines direct-to-consumer e-commerce through biomiga.com/shop with a global distributor network reaching 60+ countries, supported by regulatory credentials including FDA facility registration, FDA 510(k) clearance (Disposable Sampler, K210440), and CE-IVD certifications across multiple diagnostic panels. Revenue is generated primarily through one-time consumable kit sales with unit pricing ranging from $10 for basic DNA markers up to $32,500 for high-content UTI panels, supplemented by custom services and hardware sales. Cumulative production scale includes over 10 million MgPure Viral RNA preps and over 5 million COVID-19 RT-qPCR reactions shipped worldwide.

Name

Biomiga Diagnostics

Legal name

Biomiga, Inc.

Website

https://biomiga.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Biomiga Diagnostics (Biomiga, Inc.) is a San Diego-based molecular biology tools manufacturer producing nucleic acid extraction kits, PCR reagents, viral vector purification systems, and diagnostic panels from its FDA-registered facility, sold through e-commerce and a distributor network to research and clinical labs in 60+ countries.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics & Life Science Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)

Keywords

• Molecular biology reagents
• Nucleic acid extraction
• Real-time PCR detection
• Viral vector purification
• Infectious disease diagnostics

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Molecular Biology Products: Sale of laboratory reagents and kits including extraction kits, PCR reagents, viral vector purification products, and lab essentials. Products sold in various pack sizes (e.g., 50 preps, 250 preps, 100 tests, 500 tests) with pricing ranging from tens to thousands of dollars per unit.
2. Custom Services: Full-service custom support including product customization to meet exact specifications and requirements of clients.
3. Automation Equipment: Sale of automated nucleic acid extraction instruments including Mini-32, Mini-16, and compatibility with Allsheng automation platforms.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Biomiga Diagnostics manufactures and sells molecular biology tools including nucleic acid extraction kits, PCR and qPCR reagents, viral vector purification kits, real-time PCR infectious disease detection panels, automated extraction instruments, and lab consumables. Products are made in an FDA-registered, ISO 9001:2015 certified San Diego facility and sold to research and diagnostic labs worldwide, alongside custom services.

Product overview

Biomiga Diagnostics is a molecular biology tools company offering a comprehensive portfolio of extraction kits, PCR detection reagents, viral vector purification systems, automation platforms, and lab essentials manufactured in their FDA-registered San Diego facility. The product ecosystem centers on three core technology platforms: magnetic bead-based MgPure extraction technology (for automated high-throughput purification on Kingfisher, Allsheng, and Biomek platforms), spin-column EZgene technology for manual nucleic acid extraction, and multiplex real-time PCR detection panels for infectious disease diagnostics. The diagnostic product line includes respiratory panels (Full RPP, RPP 5-Plex, Respiratory Panel, SC2 FluA&B), urinary tract infection panels, sexually transmitted infection panels (STI Panel, STI 3-Plex, STI 4-Plex), gastrointestinal panels, pneumonia panels, wound panels, women's health panels, fungal panels, and monkeypox detection. The virus purification line features ViraTrap kits for adenovirus, AAV, lentivirus, and retrovirus with 60-minute purification versus 24-hour traditional methods. Automation offerings include Mini-32 and Mini 16 automatic nucleic acid extractors and the CB-12 automated plasmid maxiprep platform. Supporting products include qPCR master mixes, competent cells, lab consumables, and certified reference materials.

Differentiator

Problem solved

Functional benefit

Brands

• Ezgene™: Proprietary spin-column technology for nucleic acid extraction and purification from various biological samples
• ViraTrap™
• MgPure
• ezBind™

Products and services

• Universal Pathogen DNA/RNA Extraction Kit Spin-column based kit for isolating total viral DNA/RNA from plasma, serum, respiratory specimens, and other sample types. Tested for COVID-19, Hepatitis A, Hepatitis C, and HIV. For research and diagnostic labs.
• MgPure Universal Pathogen DNA/RNA Purification Kit Prefilled magnetic bead-based reagent kit for Kingfisher Flex, IsoPure 96, AutoPure 96 and other magnetic bead platforms. Ready-to-use format for automated pathogen DNA/RNA extraction.
• Respiratory Panel Real Time PCR Detection Kit Multiplex real-time RT-PCR test for simultaneous detection of SARS-CoV-2, Influenza A/B, RSV, Adenovirus, Human Metapneumovirus, Rhinovirus, and Parainfluenza viruses.
• Full RPP Real Time PCR Detection Comprehensive respiratory pathogen panel detecting 33 targets including Strep A, Bordetella pertussis, Flu A/B, RSV, Adenovirus, MRSA, and multiple respiratory viruses and bacteria.
• RPP 5-Plex Real Time PCR Detection Real-time RT-PCR multiplexed test for simultaneous detection and differentiation of SARS-CoV-2, Influenza A, Influenza B, RSV-A and RSV-B in respiratory samples.
• UTI Panel Real Time PCR Detection Real-time PCR panel for rapid detection of 20 UTI pathogens including bacteria and fungi (Candida species), plus antibiotic resistance genes (MecA, KPC, NDM, etc.).
• STI Panel Real Time PCR Detection Multiplex PCR panel detecting 8 sexually transmitted infection pathogens including Mycoplasma hominis, Chlamydia trachomatis, Gardnerella vaginalis, Trichomonas vaginalis, and Neisseria gonorrhoeae.
• STI 3-Plex Real Time PCR Detection Real-time PCR detection of Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhoeae in 50 minutes.
• STI 4-Plex Real Time PCR Detection Real-time PCR panel detecting Trichomonas vaginalis, Gardnerella vaginalis, Chlamydia trachomatis, and Neisseria gonorrhoeae in a single reaction.
• GI Panel Real Time PCR Detection Qualitative real-time PCR test for detection of viral, parasitic, and bacterial nucleic acids from unpreserved stool samples in Cary-Blair transport medium.
• Pneumonia Panel Real Time PCR Detection Real-time PCR panel for specific detection of 14 pneumonia-causing bacteria including Haemophilus influenzae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Streptococcus pneumoniae, and atypical pathogens.
• Monkeypox Virus Real Time PCR Detection Kit Qualitative real-time PCR test for detection of Monkeypox virus DNA extracted from lesion material, targeting MPXV specific gene with human RNase P as control.
• Nail Fungal Real Time PCR Detection Real-time PCR detection panel identifying 19 fungal pathogens in 5 PCR reactions for nail fungal infections.
• Wound Panel Real Time PCR Detection Real-time PCR test for qualitative detection of DNA from wound pathogens including bacteria and fungi (Candida species), plus antibiotic resistance genes.
• Women Health Real Time PCR Detection Multiplex real-time PCR assay for qualitative detection of 26 pathogen DNA targets associated with gynecologic infections from urine, endocervical, and vaginal swabs.
• Fungal Panel Real Time PCR Detection Real-time PCR panel for detection of invasive fungal pathogens associated with immunocompromised patient infections.
• SC2 FluA&B Real Time PCR Detection Simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B in upper or lower respiratory samples using real-time RT-PCR.
• SC2 Real Time PCR Detection Kit (3-gene) Real-time RT-PCR assay targeting RdRp, N, E genes and RNase P for specific qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
• SARS-CoV-2 Real Time PCR Assay (2-gene) Real-time RT-PCR assay targeting RdRp, E gene and RNase P for qualitative detection of SARS-CoV-2 RNA.
• ViraTrap Adenovirus Purification Kit Fast adenovirus purification kit enabling purification in 60 minutes compared to 24 hours for traditional CsCl ultracentrifugation. Produces up to 3x10^12 Vps per preparation.
• ViraTrap AAV Purification Kit Fast adeno-associated virus purification kit for all serotypes, purifying AAV in 60-120 minutes versus 24 hours for traditional methods. Produces up to 1x10^13 Vps.
• ViraTrap Lentivirus Purification Kit Fast lentivirus purification kit completing purification in 60 minutes versus 24 hours for CsCl ultracentrifugation. Produces up to 3x10^12 Vps per preparation.
• ViraTrap Retrovirus Purification Kit Fast retrovirus purification kit completing purification in 60 minutes versus 24 hours for traditional methods. Produces up to 1x10^12 VPs.
• Automated Anion Exchange Based Plasmid Maxiprep Platform Automated endofree plasmid maxi purification system (AP-6 and CB-12 devices) supporting ion exchange and magnetic beads methods. Processes up to 12 samples per run within 2 hours (ion exchange) or 1 hour (magnetic bead).
• Mini-32 Automatic Nucleic Acid Extractor Portable automatic nucleic acid extractor using magnetic bead adsorption separation technology, processing 1-32 samples in 9-45 minutes with 10-inch touch interface.
• Mini 16 Automatic Nucleic Acid Extractor Compact automatic nucleic acid extractor for clinical diagnostics, molecular research, and decentralized testing applications.
• Express MgPure Viral RNA Purification Kit Prefilled magnetic bead kit for simultaneous extraction of 96 viral RNA samples in 25 minutes. FDA and CE-IVD certified, validated by US COVID-19 Testing Task Force Labs.
• MgPure Viral RNA Purification Kit Magnetic bead-based viral RNA extraction kit for processing respiratory specimens with automated workflow on 96-well platforms. Over 10 million preps shipped worldwide.
• Probe-based 2X qPCR Master Mix Ready-to-use qPCR reaction cocktail containing Hot Start Taq DNA polymerase, dNTPs with dUTP, Mg2+, UNG, and stabilizers for real-time quantitative PCR.
• 5x RT-qPCR Mix One-tube 5X RT-qPCR mix for reverse transcription and PCR amplification of RNA targets with engineered reverse transcriptase and Hot Start Taq DNA polymerase.
• One Step qRT-PCR 2x Mix Two-tube system for one-step RT-qPCR with hot start PCR, broad RT reaction temperature range (40-55C), and high sensitivity (10 copies detection). Over 5 million reactions shipped for COVID-19 testing.
• MgPure Beads Superparamagnetic Fe3O4 nanoparticles with silica matrix for DNA/RNA purification. 50nm hydrodynamic diameter, 300 m2/g surface area, 15 mmol OH/g hydroxyl degree.
• Proteinase K Serine protease solution at 25 mg/mL for digesting native proteins, inactivating DNases and RNases. Stable at 15-25C for one year, retains activity in presence of SDS, urea, and guanidine salts.
• RNaseErase Solution Surface decontamination solution for removing RNases from plastic and glass surfaces on contact without inhibiting subsequent enzymatic reactions.
• Disposable Sampler FDA 510k approved (K210440) viral transport medium kit with flocked nylon swab for collection, storage and transportation of nasopharyngeal virus samples.
• EZgene 96 PCR Purification Kit High-throughput purification system for up to 96 PCR products simultaneously using proprietary EZgene matrix technology. Recovers DNA fragments 100 bp to 10 kb with >80% yield.
• Gel Extraction Kit Spin-column kit for recovering DNA from agarose gels and purifying PCR fragments. DNA fragments 70 bp to 20 kb with 80-90% recovery.
• DNA Markers DNA ladders including 100bp (11 bands, 100-1500 bp) and 1KB (14 bands, 200-10000 bp) markers for agarose gel electrophoresis.
• Filter Pipette Tips Low retention filter tips in volumes 10uL to 1250uL, DNase/RNase free, compatible with GILSON, EPPENDORF, THERMO, BIOHIT, CAPP pipettes.
• DH5a Chemically Competent Cells E. coli host strain for routine bacterial transformation, plasmid propagation, subcloning, and library construction.
• CJ236 Chemically Competent Cells E. coli strain for generating uracil-containing ssDNA for Kunkel-method site-directed mutagenesis, with F-factor CamR for M13 phage infection.
• CJ236 Electro Competent Cells Electrocompetent cells for high-efficiency electroporation-based transformation suitable for library construction and low-copy plasmid transformation.
• Custom Services Full-service custom support including product customization to meet exact specifications and requirements of clients.

Quantifiable outcome

• 20-50% lower cost than AMPure XP competitor products
• +6 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration13 records

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Zymo Research: Privately held US molecular biology tools company of similar size and product mix — nucleic acid extraction kits, PCR reagents, and epigenetics consumables sold globally to research and clinical labs. Direct overlap with Biomiga's extraction and PCR reagent product lines and similar US-based private-company profile.
• Omega Bio-tek: Privately held manufacturer of nucleic acid purification kits (Mag-Bind, E.Z.N.A.) and PCR reagents serving research and molecular diagnostics customers. Closely comparable in catalog scope (extraction + viral RNA/DNA + automation-compatible magnetic beads) and target customer base to Biomiga.
• Macherey-Nagel: Family-owned German manufacturer of NucleoSpin, NucleoMag, and PCR clean-up kits — a long-established direct competitor in spin-column and magnetic bead nucleic acid extraction with a comparable reagent-plus-automation portfolio and global reach.
• Norgen Biotek: Privately held Canadian molecular biology tools company of comparable size offering nucleic acid purification kits, PCR reagents, and laboratory consumables for research and diagnostics. Similar private-company dynamics and a directly overlapping SKU portfolio with Biomiga.
• Bio Basic: Privately held manufacturer of molecular biology reagents, plasmid/RNA/DNA extraction kits, and lab consumables with global e-commerce distribution. Comparable catalog scope and SMB/research customer mix to Biomiga.
• ABM (Applied Biological Materials): Privately held Canadian molecular biology tools company selling PCR reagents, nucleic acid extraction kits, viral vector tools (lentivirus/AAV), and competent cells. Closely comparable to Biomiga in catalog breadth across extraction, viral vectors, and PCR reagents, and in serving research and cell/gene therapy customers.

Broad incumbents

• Qiagen: Large global life sciences tools leader with the QIAamp, QIAcube, and EZ1 extraction platforms, plus a broad PCR/IVD portfolio. Directly competes with Biomiga across most reagent and automation categories but at vastly larger scale and with deeper enterprise sales coverage.
• Takara Bio: Mid-sized Japan/US molecular biology tools company with a major presence in viral vector purification (Lenti-X, AAVpro) and PCR reagents. Directly comparable in the gene therapy workflow (ViraTrap vs Lenti-X/AAVpro) and a stronger established player in the same end markets.
• Promega: Privately held US life sciences tools company with a broad nucleic acid extraction (ReliaPrep, Maxwell), PCR, and IVD reagent portfolio. Larger incumbent with overlapping product categories (extraction, qPCR, clinical molecular diagnostics) and direct competition for Biomiga's clinical and research customers.
• New England Biolabs: Privately held US molecular biology reagents leader offering a comprehensive portfolio including nucleic acid purification (Monarch), PCR/qPCR reagents (Luna), and a growing cell and gene therapy offering. Direct overlap with Biomiga's reagent platforms and a much larger, deeply established competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/biomiga
• Facebookfacebook.com/biomiga.inc
• LinkedInlinkedin.com/company/biomiga-inc

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomiga Diagnostics